4Accepted Sep 23, 9:12 PM ET
Newcleo (NWCL) CEO Stefano Buono Receives 2.08M Equity Awards
Accepted (ET)
9:12 PM
Sep 23, 2026
Filed
Sep 23, 2026
Documents
1
Size
17.1 KB
Summary
Newcleo (NWCL) CEO Stefano Buono Receives 2.08M Equity Awards
What Happened
- Stefano Buono, CEO of Newcleo plc (NWCL), was granted a series of derivative equity awards on September 21, 2026 totaling 2,081,690 units. The grants are reported at $0.00 per unit (no cash paid at grant) and consist of a mix of performance-based earnout options, time‑based stock options, and Class B shares convertible into ordinary shares under specified conditions. These are awards (not open‑market purchases or sales) and will vest or convert only if the stated service and/or price conditions are met.
Key Details
- Transaction date: 2026-09-21; Form 4 filed: 2026-09-23 (appears timely).
- Total units granted: 2,081,690 derivative awards, reported at $0.00 per unit.
- Grant breakdown (as reported): 134,596 / 4,291 / 9,814 / 11,960 / 1,921,029 units (individual line items in the filing).
- Shares owned after transaction: Not specified in the provided summary of the filing.
- Notable footnotes from the filing:
- F1: Company Earnout Bonus Options — 50% vest if VWAP ≥ $15 over any 20 of 30 trading days; 50% vest if VWAP ≥ $18 on any trading day; price attainment period Sept 21, 2026–Sept 21, 2031; also subject to service vesting.
- F2–F4: Time‑based stock options that vest over four years from specified grant/measurement dates (Dec 1, 2025; Sept 1, 2023; Sept 1, 2022) subject to continued employment and any accelerated vesting provisions.
- F5: Class B Shares issued under the Business Combination Agreement that automatically convert one‑for‑one into ordinary shares upon the same $15/$18 VWAP triggers (conversion window begins Sept 21, 2026 and runs for five years).
- Filing timeliness: The Form 4 was filed two days after the reported transaction date, consistent with the standard two‑business‑day reporting requirement (no late filing indicated).
Context
- These are derivative awards and contingent equity — no cash changed hands at grant and the units do not become tradable ordinary shares unless/ until vesting and any price triggers are met (or converted per the BCA). Because many of the grants are tied to service vesting or future price thresholds, they represent long‑term compensation incentives rather than an immediate market purchase or sale.